KING OF PRUSSIA, Pa., Jan. 31, 2019 /PRNewswire/ — Camber Spine, a leading innovator in spine and medical technologies, today reported preliminary unaudited proprietary sales results (sales of products innovated and owned by the company) for the fourth quarter and full year ending December 31, 2018. These preliminary unaudited results include:
Fourth quarter 2018, proprietary sales growth of 38% over the fourth quarter of 2017.
Full year 2018, proprietary sales growth of 36% over the prior year.
The growth was largely driven by the growth of the SPIRA® and ENZA®, Camber’s proprietary technology platforms, which yielded year-over-year sales growth of 271%, and the addition of over 60 new surgeon users. The company also launched four new products in 2018: SPIRA®-C Open Matrix Cervical Interbody, TI-DIAGON™ Anatomic Oblique TLIF, the second generation of ENZA®-A Titanium 3D-printed MIS ALIF, and SPIRA®-V Open Matrix Corpectomy.
“We are extremely pleased with these sales results and in particular the incredible surgeon acceptance of the new ENZA®-A” said Seth Anderson, Vice President of New Business Development and Surgeon Relations. “With ENZA®-A’s successful beta launch in 2018, Camber now owns the very best ALIF implant in the industry. 2019 should deliver even stronger sales growth”.
The company expects continued significant growth of proprietary sales in 2019 driven by further product launches and market enthusiasm for the SPIRA® and ENZA® product platforms and the launch of at least three new products outside these core growth platforms.
About Camber Spine
Camber Spine Technologies, LLC, is a medical device company focused on the design, development and commercialization of innovative and proprietary musculoskeletal implant systems. The company is committed to delivering surgeon inspired new technologies to the spine market. Camber Spine, located in King of Prussia, Pennsylvania, markets a line of proprietary musculoskeletal products nationwide.
All of Camber Spine’s products are proudly MADE IN THE USA.